GlassScriptPhysician profile
George Willard Sledge
NPI 1780640318
$49,991.51
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36K · 2020: $3,050 · 2021: $4,412 · 2022: $6,800.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Radius Health, INC. | $25,000.00 | 2019 | |
| Eli Lilly and Company | $12,888.48 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $6,600.00 | 2021-2022 | |
| Lilly USA, LLC | $3,200.00 | 2022 | |
| Varian Medical Systems, INC. | $2,096.67 | 2019-2020 | |
| Seagen INC. | $109.21 | 2019 | |
| Genentech USA, INC. | $85.23 | 2019 | |
| Gilead Sciences, INC. | $11.92 | 2021 |
3 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Sledge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.